India and Brazil on Saturday exchanged a Memorandum of Understanding (MoU) aimed at strengthening bilateral cooperation in the regulation of pharmaceutical and medical products, marking a significant step in expanding health sector collaboration between the two countries.
The MoU was signed between India’s Central Drugs Standard Control Organisation (CDSCO) and Brazil’s Brazilian Health Regulatory Agency (ANVISA) at Hyderabad House. The agreement was exchanged by ANVISA Director-President Leandro Safatle and India’s Ambassador to Brazil, Dinesh Bhatia, in the presence of Prime Minister Narendra Modi and Brazilian President Luiz Inacio Lula da Silva.
The MoU establishes a structured framework for cooperation and information exchange in the regulation of medical products, including pharmaceutical ingredients, drugs, biological products and medical devices. It seeks to promote convergence in regulatory practices, deepen mutual understanding of regulatory systems and facilitate coordinated oversight of medical products.
The Ministry of Health and Family Welfare (MoHFW) said the agreement reflects the shared commitment of both nations to ensuring the availability of safe, effective and quality-assured medicines and medical products for their populations. The partnership is also expected to strengthen supply chains, encourage regulatory best practices and improve access to affordable healthcare solutions.
The new understanding builds on the broader India-Brazil cooperation in the health sector and complements existing bilateral engagement mechanisms. It highlights growing collaboration in pharmaceuticals and medical technologies, particularly as both countries continue to champion the interests of the Global South.
Under the MoU, both sides will cooperate in areas such as information sharing, regulatory capacity building and collaboration in pharmaceutical and medical product regulation, in accordance with their respective national laws and regulations.
The agreement is expected to open new avenues for collaboration in health and pharmaceuticals, further reinforcing India-Brazil ties while contributing to improved public health outcomes in both countries.
